Hepatocellular Carcinoma (HCC): Are We Performing Too Many Liver Biopsies? | 12247

OMICS Journal of Radiology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Hepatocellular Carcinoma (HCC): Are we performing too many liver biopsies?

International Conference on Radiology & Imaging

Samantha Low

ScientificTracks Abstracts: OMICS J Radiology

DOI: 10.4172/2167-7964.S1.002

Aim: Once a diagnosis of HCC is made on Magnetic Resonance Imaging (MRI), a liver biopsy is often undertaken for tissue diagnosis. We examined whether biopsy in such cases is really necessary. Methods & Results: Of all 998 liver biopsies performed in our University Hospital between January 2007 and January 2013, 26 had a histological diagnosis of HCC. 8 of these had prior liver MRI, of which 4 were reported as HCC. In all 4 cases, the alpha fetoprotein (AFP) was raised. On the other hand, 25 of the 26 patients had prior Computer-assisted Tomography (CT), with only 5 reported as HCC. Moreover, of all 95 urgent or scheduled MRI Liver scans performed in our hospital between Jan 2011 and Dec 2012, 2 were reported as HCC, and both were confirmed on biopsy. Discussion: Whilst our study, to date, has limited power, we advocate MRI as a first line investigation for suspected HCC. Moreover, in cases where the MRI shows a diagnosis of HCC and the AFP is raised, we argue that a liver biopsy, which itself carries risks, may not be necessary. However, in cases where the AFP is raised, and the MRI is suspicious for HCC, but cannot exclude metastasis, we would advocate a liver biopsy. This is because there are reported cases in the literature of AFP-producing gastric cancers with liver metastases.